Jason A. Leverone insider trades

Open-market stock purchases and sales by Jason A. Leverone, Chief Financial Officer at OnKure Therapeutics, Inc, from SEC Form 4 filings since Feb 16, 2017.

Recent trades

DateStockTradeValue
Sep 21, 2026OKUR OnKure Therapeutics, IncSold$898
Aug 7, 2026OKUR OnKure Therapeutics, IncSold (not open market)$123K
Aug 7, 2026OKUR OnKure Therapeutics, IncBought (not open market)$23.9K
Aug 7, 2026OKUR OnKure Therapeutics, IncSold (not open market)$74.5K
Aug 7, 2026OKUR OnKure Therapeutics, IncBought (not open market)$22K
Aug 7, 2026OKUR OnKure Therapeutics, IncSold (not open market)$2.4M
Aug 7, 2026OKUR OnKure Therapeutics, IncBought (not open market)—
Aug 7, 2026OKUR OnKure Therapeutics, IncBought (not open market)$541K
Jun 22, 2026OKUR OnKure Therapeutics, IncSold$1.3K
Apr 1, 2026OKUR OnKure Therapeutics, IncBought (not open market)—
Mar 23, 2026OKUR OnKure Therapeutics, IncSold$1.3K
Dec 22, 2025OKUR OnKure Therapeutics, IncSold$896

Companies traded

  • OKUR OnKure Therapeutics, Inc: 8 sales, last Sep 21, 2026
  • VRDN Viridian Therapeutics, Inc.\DE: other filings, last Jan 18, 2021
  • MGEN Miragen Therapeutics, Inc: other filings, last Mar 13, 2020

Get free alerts when Jason A. Leverone files a new trade →